Pure Global AI
NCT06217276Recruiting

Respiratory Muscle Fatigue and Lower Extremity Muscle Oxygenation

Examining the Relationship Between Respiratory Muscle Fatigue and Lower Extremity Muscle Oxygenation in Chronic Obstructive Pulmonary Disease Patients.
Istanbul Medipol University HospitalClinicalTrials.govother
Verified
Study focus
Disease/Condition
COPD
Drug/Device/Intervention
Respiratory muscle fatigue protocol
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Istanbul Medipol University Hospital
Location
Istanbul, Turkey
Timeline & enrollment
Phase
N/A
Start date
Jan 20, 2024
End date
Jan 15, 2025
Enrollment
30 participants
Primary outcome

Lower extremity muscle oxygenation level measurement,Lower extremity muscle total hemoglobin amount level measurement

Summary

In our study, changes in vastus lateralis muscle oxygenation will be evaluated with the Moxy
 device, a functional infrared oxygen measurement device, during the inspiratory muscle
 fatigue protocol in COPD cases and the healthy control group.

ICD-10 classifications
Chronic obstructive pulmonary disease, unspecifiedOther chronic obstructive pulmonary diseaseOther specified chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease with acute exacerbation, unspecifiedPulmonary heart disease, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06217276
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06217276 through Pure Global AI's free database. This phase not specified trial is sponsored by Istanbul Medipol University Hospital and is currently Recruiting. The study focuses on COPD. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.